Low-Dose Sirolimus Immunoregulation Therapy in Patients with Active Rheumatoid Arthritis:

Joseph · 2023-01-16T12:25:13.038Z

An older paper, published 03rd of November 2019

Low-Dose Sirolimus Immunoregulation Therapy in Patients with Active...

Background. We have reported previously the insufficient absolute number or functional defects of regulatory T cells (Tregs) in patients with rheumatoid arthritis (RA), challenging conventional unspecific immunosuppressive therapy. Sirolimus, a mTOR...